When does the mind begin? Infant psychology is mysterious in part because we cannot remember our first months of life, nor can we directly communicate with infants. Even more speculative is the possibility of mental life prior to birth. The question of when consciousness, or subjective experience, begins in human development thus remains incompletely answered, though boundaries can be set using current knowledge from developmental neurobiology and recent investigations of the perinatal brain. Here, we offer our perspective on how the development of a sensory perturbation complexity index (sPCI) based on auditory (“beep-and-zip”) or visual (“flash-and-zip”) cortical perturbations in place of electromagnetic perturbations (“zap-and-zip”) might be used to address this question. First, we discuss recent studies of perinatal cognition and consciousness using techniques such as functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and, in particular, magnetoencephalography (MEG). While newborn infants are the archetypal subjects for studying early human development, researchers may also benefit from fetal studies, as the womb is, in many respects, a more controlled environment than the cradle. The earliest possible timepoint when subjective experience might begin is likely the establishment of thalamocortical connectivity at 26 weeks gestation, as the thalamocortical system is necessary for consciousness according to most theoretical frameworks. To infer at what age and in which behavioral states consciousness might emerge following the initiation of thalamocortical pathways, we advocate for the development of the sPCI to estimate the perinatal brain’s state of consciousness.
Recently, the possibility of misrepresentation has resurfaced in the debate between higher-order thought theorists and their opponents. One new element in the debate has been the rare cases of Charles Bonnet syndrome (RCB cases), as proposed empirical evidence for misrepresentation as posited by the higher-order theories. In this article I will spell out the argument supposedly underlying the claim that the RCB cases are genuine empirical evidence of misrepresentation. I will then proceed to show that this argument relies on a hidden premiss. With this premiss exposed the argument cannot support the notion of misrepresentation posited by higher-order theories.
Subjective experience has often taken center stage in debates between competing conceptual theories of the mind. This is also a central object of concern in the empirical domain, and especially in the search for the neural correlates of consciousness (NCCs). By now, most of the competing conceptual theories of consciousness have become aligned with distinct hypotheses about the NCCs. These hypotheses are usually distinguished by reference to their proposed location of the NCCs. This difference in hypothesized location of the NCCs has tempted participants in these debates to infer that evidence indicating the location of the NCCs in one or the other brain region can be taken as direct evidence for or against a given conceptual theory of consciousness. We argue that this is an overestimation of the work finding the NCCs can do for us, and that there are principled reasons to resist this kind of inference. To show this we point out the lack of both an isomorphism and a homomorphism between the conceptual frameworks in which most theories are cached, and the kind of data we can get from neuroimaging. The upshot is that neural activation profiles are insufficient to distinguish between competing theories in the conceptual domain. We suggest two ways to go about ameliorating this issue.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.